Glenmark to commercialize AstraZeneca’s asthma drug in Columbia
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Key takeaways of recent quarter & conference call highlights
It is being developed by Pune-based Gennova Biopharmaceuticals
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated